WEST PHARMACEUTICAL SERVICES INC (WST) Operating Income (Loss) USD 2010 - 2024

Historical data

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: West Pharmaceutical Services Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2024.
West Pharmaceutical Services Inc Operating Income (Loss) for the quarter ending March 31, 2024 was $123 M, a 20.9% decline year-over-year.
West Pharmaceutical Services Inc Operating Income (Loss) for the twelve months ending March 31, 2024 was $644 M, a 8.02% decline year-over-year.
West Pharmaceutical Services Inc annual Operating Income (Loss) for 2023 was $676 M, a 7.9% decline from 2022.
West Pharmaceutical Services Inc annual Operating Income (Loss) for 2022 was $734 M, a 2.43% decline from 2021.
West Pharmaceutical Services Inc annual Operating Income (Loss) for 2021 was $752 M, a 84.9% increase from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2024	$644 M	$123 M	-$32.5 M	-20.9%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-04-25
Q4 2023	$676 M	$161 M	+$31.2 M	+24.1%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-20
Q3 2023	$645 M	$177 M	-$8.9 M	-4.78%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-10-26
Q2 2023	$654 M	$183 M	-$45.9 M	-20.1%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-07-27
Q1 2023	$700 M	$155 M	-$34.4 M	-18.1%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-04-25
Q4 2022	$734 M	$130 M	-$54.3 M	-29.5%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-20
Q3 2022	$788 M	$186 M	+$4.8 M	+2.65%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-10-26
Q2 2022	$784 M	$228 M	+$17.1 M	+8.09%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-07-27
Q1 2022	$766 M	$190 M	+$14.1 M	+8.03%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-04-27
Q4 2021	$752 M	$184 M	+$67.9 M	+58.5%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-20
Q3 2021	$684 M	$181 M	+$82.2 M	+82.9%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-10-27
Q2 2021	$602 M	$211 M	+$108 M	+104%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-07-28
Q1 2021	$495 M	$176 M	+$87.6 M	+99.5%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-04-28
Q4 2020	$407 M	$116 M	+$38 M	+48.7%	Oct 1, 2020	Dec 31, 2020	10-K	2023-02-21
Q3 2020	$369 M	$99.2 M	+$31.9 M	+47.4%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-10-28
Q2 2020	$337 M	$104 M	+$23.1 M	+28.7%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-07-30
Q1 2020	$314 M	$88 M	+$17.3 M	+24.5%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-04-30
Q4 2019	$297 M	$78.1 M	+$12.3 M	+18.7%	Oct 1, 2019	Dec 31, 2019	10-K	2022-02-22
Q3 2019	$284 M	$67.3 M	+$6.5 M	+10.7%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-10-23
Q2 2019	$278 M	$80.5 M	+$20.2 M	+33.5%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-07-24
Q1 2019	$258 M	$70.7 M	+$17.3 M	+32.4%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-04-24
Q4 2018	$240 M	$65.8 M	+$5.4 M	+8.94%	Oct 1, 2018	Dec 31, 2018	10-K	2021-02-23
Q3 2018	$235 M	$60.8 M	-$2.1 M	-3.34%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-10-29
Q2 2018	$237 M	$60.3 M	+$18.3 M	+43.6%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-07-29
Q1 2018	$219 M	$53.4 M	-$7.1 M	-11.7%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-08
Q4 2017	$226 M	$60.4 M	+$7.7 M	+14.6%	Oct 1, 2017	Dec 31, 2017	10-K	2020-02-24
Q3 2017	$218 M	$62.9 M	+$11.6 M	+22.6%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-10-30
Q2 2017	$207 M	$42 M	-$19.2 M	-31.4%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-07-31
Q1 2017	$226 M	$60.5 M	+$30.5 M	+102%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-08
Q4 2016	$195 M	$52.7 M	+$7.5 M	+16.6%	Oct 1, 2016	Dec 31, 2016	10-K	2019-02-28
Q3 2016	$188 M	$51.3 M	+$54.8 M		Jul 1, 2016	Sep 30, 2016	10-Q	2017-10-31
Q2 2016	$133 M	$61.2 M	+$22.1 M	+56.5%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-01
Q1 2016	$111 M	$30 M	-$17.8 M	-37.2%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-05
Q4 2015	$129 M	$45.2 M	+$600 K	+1.35%	Oct 1, 2015	Dec 31, 2015	10-K	2018-02-26
Q3 2015	$128 M	-$3.5 M	-$47.5 M	-108%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-10-31
Q2 2015	$176 M	$39.1 M	-$15 M	-27.7%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-01
Q1 2015	$191 M	$47.8 M	+$8.5 M	+21.6%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-06
Q4 2014	$182 M	$44.6 M	+$7.7 M	+20.9%	Oct 1, 2014	Dec 31, 2014	10-K	2017-02-28
Q3 2014	$174 M	$44 M	+$4.3 M	+10.8%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-02
Q2 2014	$170 M	$54.1 M	+$11.6 M	+27.3%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-03
Q1 2014	$158 M	$39.3 M	-$4 M	-9.24%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-06
Q4 2013	$162 M	$36.9 M	+$5.4 M	+17.1%	Oct 1, 2013	Dec 31, 2013	10-K	2016-02-26
Q3 2013	$157 M	$39.7 M	+$13.4 M	+51%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-03
Q2 2013	$144 M	$42.5 M	+$6.9 M	+19.4%	Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-01
Q1 2013	$137 M	$43.3 M	+$1.6 M	+3.84%	Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-08
Q4 2012	$135 M	$31.5 M	+$4.6 M	+17.1%	Oct 1, 2012	Dec 31, 2012	10-K	2015-02-25
Q3 2012	$131 M	$26.3 M	+$200 K	+0.77%	Jul 1, 2012	Sep 30, 2012	10-Q	2013-11-04
Q2 2012	$130 M	$35.6 M	+$7.8 M	+28.1%	Apr 1, 2012	Jun 30, 2012	10-Q	2013-08-05
Q1 2012	$123 M	$41.7 M	+$12.9 M	+44.8%	Jan 1, 2012	Mar 31, 2012	10-Q	2013-05-06
Q4 2011	$110 M	$26.9 M	+$20.9 M	+348%	Oct 1, 2011	Dec 31, 2011	10-K	2014-02-27
Q3 2011	$88.7 M	$26.1 M	+$800 K	+3.16%	Jul 1, 2011	Sep 30, 2011	10-Q	2012-11-05
Q2 2011	$87.9 M	$27.8 M	-$2.7 M	-8.85%	Apr 1, 2011	Jun 30, 2011	10-Q	2012-08-06
Q1 2011	$90.6 M	$28.8 M	-$100 K	-0.35%	Jan 1, 2011	Mar 31, 2011	10-Q	2012-05-04
Q4 2010	$90.7 M	$6 M			Oct 1, 2010	Dec 31, 2010	10-K	2013-02-27
Q3 2010		$25.3 M			Jul 1, 2010	Sep 30, 2010	10-Q	2011-11-07
Q2 2010		$30.5 M			Apr 1, 2010	Jun 30, 2010	10-Q/A	2011-08-08
Q1 2010		$28.9 M			Jan 1, 2010	Mar 31, 2010	10-Q	2011-05-05

* An asterisk sign (*) next to the value indicates that the value is likely invalid.